Johns Hopkins 公開
[search 0]
もっと

Download the App!

show episodes
 
The Johns Hopkins Kimmel Cancer Center leads the field in scientific inquiry and sets the pace in the race to cure cancer. Our doctors and researchers are at the vanguard of discovery, implementation and treatment. Our podcast provides a glimpse at the work they do to combat cancer and the leading care that our state-of-the-art facilities provide.
 
The mission of the Johns Hopkins Hospital Nursing Research Program is to inspire and engage with nurses to participate in and disseminate the three forms of inquiry: evidence-based practice, quality improvement, and research. The Center for Nursing Inquiry’s purpose is to increase the competence, confidence and capacity of Hopkins nurses to engage in meaningful scholarly activities.
 
Johns Hopkins Medicine is pleased to present its health and medicine podcast, a lively discussion of the week’s medical news and how it may affect you. This five to seven-minute free program features Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine, and Rick Lange M.D., professor of medicine at Johns Hopkins and vice chairman of medicine at the University of Texas Health Science Center at San Antonio.
 
Join physicians at Johns Hopkins Medicine for its women’s health podcast series, A Woman’s Journey: Insights That Matter, on the first Thursday of each month. Host Lillie Shockney, acclaimed humorist cancer survivor, and nurse, discusses Women and Heart Disease; Symptoms You Shouldn’t Ignore; Mindfulness; Sleep; The Microbiome; Advances in Breast Cancer Treatment; Brain Research; A-fib; Kidney Disease in Women of Color; and Memory with Johns Hopkins experts. Learn about medical advances and ...
 
This podcast provides daily updated information on the spread and containment of the Coronavirus (SARS-CoV-2) including confirmed cases, mortality rates and significant news on its global spread and mitigation, with focus on events in the United States. Please write a nice review. Information sources: U.S. CDC, Johns Hopkins University, WHO And from these major news publications (with credit attribution): Associated Press Thomas-Reuters The Epoch Times Executive Producer James Watkins is a 3 ...
 
The American Health Podcast is created by the Bloomberg American Health Initiative, a project of the Johns Hopkins Bloomberg School of Public Health. The Initiative works to tackle some of the most pressing challenges to public health in the United States: Addiction and Overdose, Environmental Challenges, Obesity and the Food System, Risks to Adolescent Health and Violence. Visit http://americanhealth.jhu.edu to learn more.
 
Dr. Mark Vaughan reviews COVID-19 (Coronavirus or SARS-CoV-2) pandemic news updates daily each weekday. Updates are based on daily news and scientific reports and are usually shorter than 5 minutes. Most of the information is gleaned from the Johns Hopkins Center for Health Security daily updates among other sources of health and medical news stories. Dr. Vaughan is the Medical Director of the Auburn Medical Group. He also serves on the Board of Directors for Sutter Independent Physicians. L ...
 
Jessica Houston is an award winning, Johns Hopkins-trained nutritionist, creator of EatClean30 and founder of Vitamin & Me. She is deconstructing the health space and bringing you access and clear guidance straight from the world's leading experts on strategies to increase healthspan, mental and physical wellbeing through a deeper understanding of nutrition, fitness and wellness. On this podcast, we take you behind the scenes with top global health leaders so you can learn what proper nutrit ...
 
Two physicians, through dialogue and interviews, take a critical look at medical training and the culture of medicine and explore how interpersonal boundary clarity and the capacity to fully engage are essential to effective medical practice, mentoring, medical education, and a nourishing career. This podcast builds on Dr. Weiner’s book, On Becoming a Healer: The Journey from Patient Care to Caring about Your Patients (Johns Hopkins University Press, 2020). Hosted by Saul J. Weiner MD, and S ...
 
Strength & Speed podcast focuses on Obstacle Course Racing ( OCR ) improvement by pulling in lessons learned from other sports. Hosted by Pro OCR athlete and Army Special Forces veteran Evan Perperis. Evan is a NSCA-CPT, the author of 6x books on Obstacles Course Racing, with an undergrad from Johns Hopkins and has a Masters from KU. An accomplished OCR athelte with 55+ OCR podiums including winning the team division at the 24 hour long 2018 World’s Toughest Mudder and 2nd place Pro Coed Tea ...
 
The Locked On Orioles Podcast is the daily podcast giving you unrivaled coverage of the Baltimore Orioles. Hosted by Johns Hopkins play-by-play voice and lifelong Orioles fan Connor Newcomb, the podcast dives into news, analysis, stats, and opinion on all the happenings in the Warehouse and at the Yard from your host and special guests. The Locked on Orioles Podcast is part of the Locked On Podcast Network.
 
The Bologna Institute for Policy Research (BIPR) is the research division of the Johns Hopkins University School of Advanced International Studies (SAIS) in Europe. Its purpose is to promote problem-centered, interdisciplinary research in international policy by drawing upon the global network of SAIS faculty, students and scholars. BIPR SeminarCasts are made available to the public with the goal of providing a pivotal forum for thought and debate in international public policy.
 
O podcast trata sobre temas diversos de economia e os impactos da crise do novo coronavírus nessa área. O que os governos devem fazer? Que ações devem tomar? Monica de Bolle, é PhD em Economia pela London School of Economics. Atualmente é pesquisadora-sênior do Peterson Institute for International Economics (PIIE) e diretora do Programa de Estudos Latino Americanos da Johns Hopkins University, em Washington, D.C. Traz diariamente reflexões sobre economia em linguagem simples e acessível a to ...
 
Each week Andrew Parasiliti, president of the award-winning news site Al-Monitor, and Amberin Zaman, Al-Monitor’s Senior Correspondent, interview newsmakers, journalists and thought leaders from the US and Middle East about the latest news and trends in the region. Andrew has been writing about, and traveling in, the Middle East for over three decades, meeting and interviewing the region’s top political and civil society leaders. Since obtaining his PH.D from Johns Hopkins University, he has ...
 
Carol J. Scott, MD, MSEd, FACEP, is a practicing Board Certified Emergency Physician and health educator trained at Johns Hopkins University. She is a stress management strategist and expert on the connections between stress and health. She is an award-winning speaker and One-on-One StressRelief Coach. Her medical experience and background combined with her knowledge skills and passion in the subject of stress management enables her to formulate effective, practical stressrelief solutions fo ...
 
Personal Wealthbuilders is on a mission to help everyone create wealth and have their money work for them. Your hosts Kathleen Sindell, Ph.D. and Tim Wesling, CPF will help you get on the road to financial freedom. Kathleen Sindell, Ph.D. is the author of “Investing Online for Dummies, Edtions 1-5” and teaches Personal Wealth Management at the Johns Hopkins Carey School of Business. Tim Wesling, CFP is the President of Wesling Financial where he advises individuals on the very best ways to m ...
 
Informative and entertaining stories from the editors of the journal Medicine featuring article highlights, hot topics, and other things on their minds. The journal, published every other month and now in its 90th year, includes scholarly reviews and clinical descriptions of patients from the experience of leading clinicians from around the world in the areas of internal medicine, dermatology, neurology, pediatrics, and psychiatry. The editors, David Hellmann, John Bartlett, Howard Lederman, ...
 
The treatment of diabetic retinopathy (DR) and retinal vein occlusion (RVO) is an increasingly complex and rapidly changing discipline with new information and techniques emerging. In addition, the incidence of DR and RVO is increasing dramatically. It is vital you remain up to date with the latest information, to insure your patients receive the optimal care. With that in mind, What's New in Diabetic Retinopathy & Retinal Vein Occlusion will review cutting edge therapies and techniques in D ...
 
The annual student-run Foreign Affairs Symposium at The Johns Hopkins University is returning to the Homewood campus this month, with several prominent speakers scheduled to appear during the spring semester under the theme, “From the Front Line to the Bottom Line.” All of the events are free and open to the public and take place at 8 p.m. in Shriver Hall Auditorium on their appointed dates. Each lecture is followed by a reception with the speaker and a book signing, if applicable. Retired G ...
 
Lema, um podcast do Instituto Mercado Popular, é apresentado por Carlos Góes. Este é um espaço para que você possa conhecer alguns dos principais cientistas sociais brasileiros que são referências em sua respectivas áreas do conhecimento. Aqui, você conhece um pouco do estado da arte da evidência científica. O objetivo é traçar uma uma ponte entre a fronteira do conhecimento científico e as políticas públicas que podem construir um Brasil mais próspero, justo e livre. Por que Lema? Na matemá ...
 
Loading …
show series
 
Dr. Daniel Larsen is the author of an upcoming book with Cambridge University Press, Plotting for Peace: American Peacemakers, British Codebreakers, and Britain at War, 1914-1917. In this riveting new account, Daniel Larsen tells the full story for the first time of how Prime Minister H.H. Asquith and his supporters secretly sought to end WWI. This…
 
Imagine you have moderate to severe depression. Would you stop taking your medicines to be part of a research study comparing psilocybin to a traditional antidepressant? That was a requirement for participants in a recently reported study, and Matthew Johnson, a psychedelics researcher at Johns Hopkins, says that’s not all. Johnson: In addition to …
 
Children don’t get severe Covid-19 disease as often as older people do. That assertion underpins decisions to travel with children and otherwise exercise fewer precautions against infection in this population. Yet Covid is not benign for kids. That’s according to Aaron Milstone, a pediatric infectious disease expert at Johns Hopkins. Milstone: It’s…
 
Assistant Professor Michelle Patch discusses the Johns Hopkins School of Nursing’s COVID-19 mobile vaccination clinics, how practitioners are being trained, and the skills students are learning through the COVID-19 pandemic. Follow on Twitter: Michelle Patch @MichellePatch24 Johns Hopkins School of Nursing @JHUNursing Episode Highlights: 0:30 Immun…
 
Dr Akila Viswanathan talks with Dr Ana Kiess from Johns Hopkins and Dr John Buatti from the University of Iowa to review the latest edition of Seminars in Radiation Oncology focusing on ‘Theranostics,’ the combining of therapeutic and diagnostic radiopharmaceuticals.Akila Viswanathan による
 
Host Connor Newcomb is joined by Nash Walker, the Host of Locked On Twins, to give a scouting report on LHP Brandon Waddell, whom the Baltimore Orioles claimed off of waivers from the Minnesota Twins this week. Connor and Nash talk: -What the Twins saw in Waddell when they claimed him from the Pirates this offseason -What led to him getting DFA'd b…
 
Mental health impacts from climate change are largely thought of as acute exposures to extreme events like hurricanes and wildfires. But there are other concerns like chronic “ecological grief” and anticipated “eco-anxiety.” Dr. Jura Augustinavicius from the Center for Humanitarian Health talks with Stephanie Desmon about research at the intersecti…
 
Dr. Ebtesam Al-Ketbi, president of the Emirates Policy Center, discusses how the Abraham Accords could help provide context for tough concessions on the most controversial issues facing Israelis and Palestinians; UAE interests and expectations in dealing with regional security and Iran; why the UAE is well-placed to help mediate in the Horn of Afri…
 
Katherine is the Director of the Office on Trafficking in Persons for the Administration of Children and Families Office on Trafficking in Persons. In this episode, you’ll learn about the public health response to human trafficking and hear how healthcare providers act as first responders for those experiencing human trafficking. A variety of resou…
 
Host Connor Newcomb breaks down the Baltimore Orioles four-game series against the Boston Red Sox from the weekend and gives his three big takeaways: 1) The alternate site helped Dean Kremer throw more strikes 2) Don't freak out about Zac Lowther's rough first major league start 3) Jorge Lopez may be better utilized in a bullpen role Support Us By …
 
For some, the pandemic has been a “perfect storm” in terms of unhealthy eating resulting in the “quaran-ten” or the COVID "19 pounds." Dr. Elena Jansen and Dr. Susan Carnell, two Johns Hopkins obesity researchers, talk with Stephanie Desmon about how COVID-related stress—combined with being at home more—has impacted our bodies and health behaviors …
 
The last BattleFrog champion/the first Battle of the Lions champion Amy "Magic" Pajcic and CTG Pro Doug Snyder join Evan to discuss some of their recent races. Amy gives a run down of the scenic Horseshoe Bend OCR in Arizona, the crew talks about all things Battle of the Lions (BOTL) and finally we talk some expectations for Indian Mud Run. Join th…
 
Imagine you have moderate to severe depression. Would you stop taking your medicines to be part of a research study comparing psilocybin to a traditional antidepressant? That was a requirement for participants in a recently reported study, and Matthew Johnson, a psychedelics researcher at Johns Hopkins, says that’s not all. Johnson: In addition to …
 
Imagine you have moderate to severe depression. Would you stop taking your medicines to be part of a research study comparing psilocybin to a traditional antidepressant? That was a requirement for participants in a recently reported study, and Matthew Johnson, a psychedelics researcher at Johns Hopkins, says that’s not all. Johnson: In addition to …
 
Imagine you have moderate to severe depression. Would you stop taking your medicines to be part of a research study comparing psilocybin to a traditional antidepressant? That was a requirement for participants in a recently reported study, and Matthew Johnson, a psychedelics researcher at Johns Hopkins, says that’s not all. Johnson: In addition to …
 
Psilocybin compared favorably with a traditional antidepressant for treating moderate to severe depression, a recent study found. Matthew Johnson, a psychedelics researcher at Johns Hopkins, says an entirely different clinical approach will be required to use psilocybin routinely for depression. Johnson: That’s really for two reasons: the environme…
 
Psilocybin compared favorably with a traditional antidepressant for treating moderate to severe depression, a recent study found. Matthew Johnson, a psychedelics researcher at Johns Hopkins, says an entirely different clinical approach will be required to use psilocybin routinely for depression. Johnson: That’s really for two reasons: the environme…
 
Psilocybin compared favorably with a traditional antidepressant for treating moderate to severe depression, a recent study found. Matthew Johnson, a psychedelics researcher at Johns Hopkins, says an entirely different clinical approach will be required to use psilocybin routinely for depression. Johnson: That’s really for two reasons: the environme…
 
Psilocybin compared favorably with a traditional antidepressant for treating moderate to severe depression, a recent study found. Matthew Johnson, a psychedelics researcher at Johns Hopkins, says an entirely different clinical approach will be required to use psilocybin routinely for depression. Johnson: That’s really for two reasons: the environme…
 
For people with depression, sometimes traditional antidepressant medicines simply don’t work. Now psychedelic medicines may be a new choice, if the results of a study comparing psilocybin to escitalopram, an antidepressant, hold up. Matthew Johnson, a psychedelics researcher at Johns Hopkins, comments. Johnson: Traditional antidepressants help many…
 
For people with depression, sometimes traditional antidepressant medicines simply don’t work. Now psychedelic medicines may be a new choice, if the results of a study comparing psilocybin to escitalopram, an antidepressant, hold up. Matthew Johnson, a psychedelics researcher at Johns Hopkins, comments. Johnson: Traditional antidepressants help many…
 
For people with depression, sometimes traditional antidepressant medicines simply don’t work. Now psychedelic medicines may be a new choice, if the results of a study comparing psilocybin to escitalopram, an antidepressant, hold up. Matthew Johnson, a psychedelics researcher at Johns Hopkins, comments. Johnson: Traditional antidepressants help many…
 
For people with depression, sometimes traditional antidepressant medicines simply don’t work. Now psychedelic medicines may be a new choice, if the results of a study comparing psilocybin to escitalopram, an antidepressant, hold up. Matthew Johnson, a psychedelics researcher at Johns Hopkins, comments. Johnson: Traditional antidepressants help many…
 
Depression can be hard to treat, with even established medicines taking time to be effective and perhaps not helping at all. Now a new study compared the psychedelic drug psilocybin with escitalopram, an established antidepressant, and the results impressed Matthew Johnson, a psychedelics researcher at Johns Hopkins, for the relief of depression. J…
 
Depression can be hard to treat, with even established medicines taking time to be effective and perhaps not helping at all. Now a new study compared the psychedelic drug psilocybin with escitalopram, an established antidepressant, and the results impressed Matthew Johnson, a psychedelics researcher at Johns Hopkins, for the relief of depression. J…
 
Depression can be hard to treat, with even established medicines taking time to be effective and perhaps not helping at all. Now a new study compared the psychedelic drug psilocybin with escitalopram, an established antidepressant, and the results impressed Matthew Johnson, a psychedelics researcher at Johns Hopkins, for the relief of depression. J…
 
Depression can be hard to treat, with even established medicines taking time to be effective and perhaps not helping at all. Now a new study compared the psychedelic drug psilocybin with escitalopram, an established antidepressant, and the results impressed Matthew Johnson, a psychedelics researcher at Johns Hopkins, for the relief of depression. J…
 
Can the psychedelic drug psilocybin be used to treat depression? That possibility was examined in a recent study comparing psilocybin to escitalopram, an established antidepressant, in people with moderate to severe depression. Matthew Johnson, a psychedelics researcher at Johns Hopkins, describes the results. Johnson: I think it’s an extremely pos…
 
Can the psychedelic drug psilocybin be used to treat depression? That possibility was examined in a recent study comparing psilocybin to escitalopram, an established antidepressant, in people with moderate to severe depression. Matthew Johnson, a psychedelics researcher at Johns Hopkins, describes the results. Johnson: I think it’s an extremely pos…
 
Can the psychedelic drug psilocybin be used to treat depression? That possibility was examined in a recent study comparing psilocybin to escitalopram, an established antidepressant, in people with moderate to severe depression. Matthew Johnson, a psychedelics researcher at Johns Hopkins, describes the results. Johnson: I think it’s an extremely pos…
 
Can the psychedelic drug psilocybin be used to treat depression? That possibility was examined in a recent study comparing psilocybin to escitalopram, an established antidepressant, in people with moderate to severe depression. Matthew Johnson, a psychedelics researcher at Johns Hopkins, describes the results. Johnson: I think it’s an extremely pos…
 
Host Connor Newcomb is joined by Sam Jellinek, the Director of Broadcasting and Communications for the Delmarva Shorebirds, to preview the 2021 season for the Baltimore Orioles Low-A affiliate. Connor and Sam talk: -How the infield of Gunnar Henderson, Darell Hernaiz, Anthony Servideo, and Jordan Westburg might be the best position group in the Ori…
 
Stopping gun violence requires more than thinking about policies and programs that focus on guns alone. Dr. Shani Buggs, a professor with the Violence Prevention Research Program at UC Davis, talks with Dr. Josh Sharfstein about how community-based violence prevention programs identify those most at risk of being involved in violence and connect th…
 
Host Connor Newcomb is joined by Bob Phelan, the Co-Host of the BSL 'On the Verge' Podcast, to preview the 2021 season for the Aberdeen Ironbirds — the Baltimore Orioles High-A affiliate. Connor and Bob talk: -How long will it be before Grayson Rodriguez gets moved up to Double-A? -Can Garrett Stallings prove the Orioles to be the winners of the Jo…
 
Vaccinations are seen as the primary tool to prevent COVID-19 infections, but are there other things we should be doing to bring down transmission rates? Dr. Caitlin Rivers and Dr. Crystal Watson from the Center for Health Security return to the podcast to talk with Dr. Josh Sharfstein about where we are, what still needs to be done, and when they'…
 
Loading …

クイックリファレンスガイド

Google login Twitter login Classic login